BALTIMORE, Sept. 10, 2013 /PRNewswire/ -- Paragon Bioservices, a contract manufacturing organization whose expertise is the process development and manufacturing of biopharmaceuticals, announced today that it has been awarded the 2013 CMO Leadership Award for Quality and Reliability.
"We are very honored to receive this award from Life Science Leader -- especially because this is our third consecutive year," said Dr Marco Chacon, Paragon's CEO. "For more than twenty years, we have helped pharmaceutical and biotechnology companies and government agencies move forward in the development and manufacturing of vaccines (VLPs), monoclonal antibodies and therapeutic proteins. We've completed two expansions in the past 4 years in order to constantly improve these capabilities. Therefore, customer service, quality and reliability truly are key areas of focus at Paragon Bioservices. The fact that we were recognized in the top 20% by more than 10,000 pharmaceutical executives is extremely gratifying to all of us at Paragon."
According to Jon Howland, Vice President of Publishing at Life Science Leader magazine, "These awards were conceived to better serve pharmaceutical and biopharmaceutical executives in their vetting process. It gives them information on what their peers think of a wide range of CMOs and helps them to ultimately identify the leading CMOs in the industry."
ABOUT PARAGON BIOSERVICES, INC.
Paragon is a Contract Research & GMP Manufacturing Organization (CMO) delivering research, process development and manufacturing services. Paragon's focus is biopharmaceuticals -- including recombinant proteins, viral vectors, vaccines, VLPs, and bacteriophage. Our clients include pharmaceutical companies, biotechnology companies and federal agencies. Our GMP space includes microbial and mammalian suites, fill-finish, and full
|SOURCE Paragon Bioservices, Inc.|
Copyright©2012 PR Newswire.
All rights reserved